While the specific mechanisms underlying this metabolic switch remain undefined, our findings provide new insights into MRPL12 acetylation and lay a foundation for future investigations into the therapeutic potential of modulating MRPL12 acetylation in ccRCC. This evidence concerns the gene MRPL12 and nonpapillary renal cell carcinoma.